Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionKeebeck Wealth Management, LLC
Latest Disclosed Ownership4,185 shares
Latest Disclosed Value $ 583,263
Keebeck Wealth Management, LLC reports 27.13% increase in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Keebeck Wealth Management, LLC filed a 13F-HR form disclosing ownership of 4,185 shares of Gilead Sciences, Inc. (CH:GILD) valued at $583,263 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,292 shares of Gilead Sciences, Inc.. This represents a change in shares of 27.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 4,185 893 27.13 583 44.31 0.0656
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,292 154 4.91 404 16.09 0.0466
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,138 196 6.66 348 6.75 0.0412
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,942 114 4.03 326 3.16 0.0427
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,828 340 13.67 317 37.99 0.0468
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 2,488 2,488 230 0.0331
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 0 -2,770 -100.00 0 -100.00
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 2,770 2,770 224 0.0370
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 0 -2,368 -100.00 0 -100.00
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,368 2,368 203 0.0357
2021-02-16 2020-12-31 13F Gilead Sciences COM 375558103 0 -3,416 -100.00 0 -100.00
2020-11-02 2020-09-30 13F Gilead Sciences COM 375558103 3,416 1,023 42.75 215 16.85 0.0444
2020-08-06 2020-06-30 13F Gilead Sciences COM 375558103 2,393 2,393 184 0.0582
2020-05-14 2020-03-31 13F Gilead Sciences COM 375558103 0 -2,375 -100.00 0 -100.00
2020-02-14 2019-12-31 13F Gilead Sciences COM 375558103 2,375 2,375 154 0.0488
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.